Human somatic variation

Human somatic variations are somatic mutations (mutations that occur in somatic cells) both at early stages of development and in adult cells.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 5 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Human somatic variations are somatic mutations (mutations that occur in somatic cells) both at early stages of development and in adult cells. These variations can lead either to pathogenic phenotypes or not, even if their function in healthy conditions is not completely clear yet.

The term mosaic (from medieval Latin musaicum, meaning "work of the Muses") has been used since antiquity to refer to an artistic patchwork of ornamental stones, glass, gems, or other precious material. At a distance, the collective image appears as it would in a painting; only on close inspection do the individual components become recognizable.

In biological systems, mosaicism implies the presence of more than one genetically distinct cell line in a single organism. Occurrence of this phenomenon not only can result in major phenotypic changes but also reveal the expression of otherwise lethal genetic mutations.

Genetic mutations involved in mosaicism may be due to endogenous factors, such as transposons and ploidy changes, or exogenous factors, such as UV radiation and nicotine.

Somatic mosaicism in healthy human tissues

Somatic mosaicism arises a result of somatic mutations: genomic (or even mitochondrial) alterations of different sizes ranging from a single nucleotide to chromosome gains or loss within somatic cells. These alterations within somatic cells begin at an early stage (pre-implantation or conception) and continue during aging, giving rise to phenotypic heterogeneity within cells, which may lead to the development of diseases such as cancer.

Novel array based techniques for screening genome-wide copy number variants and loss of heterozygosity in single cells showed that chromosome aneuploidies, uniparental disomies, segmental deletions, duplications, and amplifications frequently occur during embryogenesis. Yet not all somatic mutations are propagated to the adult individual, due to the phenomenon of cell competition.

Genetic alterations involving gains or loss of entire chromosomes predominantly occur during anaphase stage of cell division. But these are uncommon in somatic cells because they are usually selected against due to their deleterious consequences.

Somatic variations during embryonic development can be represented by monozygous twins since they carry different copy number profiles and epigenetic marks that keep on increasing with age. Early research on somatic mutations in aging showed that deletions, inversion, and translocations of genetic material are common in aging mice and aging genomes tend to contain visible chromosomal changes, mitotic recombination, whole gene deletions, intragenic deletions, and point mutations.

Other factors include the loss of methylation, increasing gene expression heterogeneity correlating to genomic abnormalities, and telomere shortening. It is uncertain if transcription-based DNA repair takes part in the maintaining of somatic mutations in aging tissues. In some cells, the somatically acquired alterations can be reversed back to wild type alleles by reversion mosaicism.

This can be due to endogenous mechanism such as homologous recombination, codon substitution, second-site suppressor mutations, DNA slippage, and mobile elements.

Somatic cancer-associated mutations in normal tissues

The advent of Next-Generation Sequencing technologies has increased the resolution of mutation detection and has led to the revelation that older individuals not only accumulate chromosomal alterations but also abundant mutations in cancer driver genes. Age-associated accumulation of chromosomal alterations has been documented with a variety of cytogenetic approaches, from chromosome painting to single nucleotide polymorphism (SNP) arrays.

Numerous studies demonstrated that the clonal populations might lead to loss of organismal health through the functional decline of tissue and/or the promotion of disease processes, such as cancer. This is the reason why the aberrant clonal expansion (ACE) resulting from cancer-associated mutations are common in noncancerous tissue and accumulate with age.

This is universal in most organisms and affects multiple tissues. In the hematopoietic compartment mutations include both large structural chromosomal alterations and point mutations affecting cancer-associated genes. Some translocations appear to occur very early in life.

The frequency of these events is low in people younger than 50 years ( 12 –10 18 potential different sequences. However, this number is an overestimation, since many factors contribute to limit the diversity of the B cell repertoire, first of all the actual number of B cell in the organism.

Cardiac mosaicism

Somatic mosaicism has been noted in the heart. Sequencing suggested mosaic variation in the gap junction protein connexin in three patients out of 15 might contribute to atrial fibrillation although subsequent reports in larger numbers of patients found no examples among a large panel of genes.

At Stanford, a team led by Euan Ashley demonstrated somatic mosaicism in the heart of a newborn presenting with life threatening arrhythmia. Family-based genome sequencing as well as tissue RNA sequencing and single cell genomics techniques were used to verify the finding.

A model combining partial and ordinary differential equations with inputs from heterologous single channel electrophysiology experiments of the genetic variant recapitulated certain aspects of the clinical presentation.

See also

Antibody Cancer DNA sequencing Mosaic (genetics) Mutation Retrotransposon

Text derived from https://en.wikipedia.org/w/index.php?oldid=1366226277 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

4 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.